已收盤 09-20 16:00:00 美东时间
+0.060
+1.75%
EF Hutton analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
09-09 23:54
With U.S. stock futures trading lower this morning on Tuesday, some of the stoc...
07-30 15:30
Anixa Biosciences Announces FDA Approval of Individual Patient Ind for Its Ovar...
07-23 20:15
Anixa Biosciences Inc - Vaccine Currently Being Studied in Phase One Clinical T...
07-17 20:09
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
07-17 20:00
Anixa Biosciences (NASDAQ:ANIX) said its board has authorized a share repurchase program of up to $5 million of the company's outstanding common stock. Press Release More on Anixa Biosciences Seeking ...
07-15 20:43
Anixa Biosciences Announces $5 Million Share Repurchase Program
07-15 20:30
Anixa Biosciences, Inc (NASDAQ:ANIX), a biotechnology company focused on the tr...
07-15 20:00
Anixa Biosciences Treats Sixth Patient in Its Ovarian Cancer CAR-T Clinical Tri...
06-24 20:45
Anixa Biosciences Inc (ANIX) has provided an announcement. Anixa Biosciences, I...
03-23 04:42